论文部分内容阅读
目的:评价经内镜(ERCP)治疗急性胆源性胰腺炎的临床价值及其疗效/费用情况.方法:分析2001-01/2005-06经内镜(ERCP)治疗的53例急性胆源性胰腺炎患者以及同期经内科保守治疗的83例急性胆源性胰腺炎患者的临床资料,评价ERCP治疗的临床价值及疗效/费用情况.结果:经ERCP治疗的53例患者均顺利完成ERCP检查及治疗,术后患者病情明显好转,无明显并发症发生,与常规治疗组相比其平均住院时间明显缩短(12.64±5.04dvs25.54±12.96d,P<0.05),平均住院费用明显降低(12503.25±5342.14元vs31325.54±15790.47元,P<0.05),患者死亡率明显降低.结论:急性胆源性胰腺炎行ERCP治疗是安全有效的,可明显缩短平均住院时间、降低平均住院费用及患者死亡率.
Objective: To evaluate the clinical value and efficacy / cost of endoscopic (ERCP) in the treatment of acute gallstone pancreatitis.Methods: 53 cases of acute gallstone disease treated by endoscopic (ERCP) And clinical data of 83 patients with acute gallstone pancreatitis treated conservatively during the same period were retrospectively analyzed to evaluate the clinical value and efficacy / cost of ERCP.Results: All 53 patients undergoing ERCP successfully completed the ERCP examination and The average hospitalization time was significantly shorter (12.64 ± 5.04d vs 25.54 ± 12.96d, P <0.05) and the average hospitalization cost was significantly lower than that of the conventional treatment group (12503.25 ± 5342.14 yuan vs31325.54 ± 15790.47 yuan, P <0.05), and the mortality of patients was significantly reduced.Conclusion: ERCP treatment of acute gallstone pancreatitis is safe and effective, which can shorten the average hospitalization time, reduce the average hospitalization costs and patients mortality rate.